Advanced Dome cellulose/alginate/chitosan composite matrix design with gastric and intestinal co-targeting capacities

Int J Pharm. 2022 Nov 25:628:122226. doi: 10.1016/j.ijpharm.2022.122226. Epub 2022 Oct 1.

Abstract

Dome matrix was designed with gastric and intestinal targeting capacities using melatonin and caffeine as model drugs, and alginate, chitosan and cellulose as composite materials. The melatonin, caffeine and intermediate hydroxypropylmethylcelluose-based dispersible modules were prepared through compaction. Caffeine piled module was capped at both ends with melatonin void modules via intermediate dispersible modules into Dome matrix. Dispersion of intermediate module detached melatonin module from Dome matrix and had it floated in stomach providing a more complete melatonin release due to favorable pH-pKa relationship of dissolution medium and drug. With reference to the caffeine module, the detachment of melatonin module facilitated its gastrointestinal transit as a reduced size matrix, with majority of caffeine delivered in colon. The dual site-targeted and -release Dome matrix is applicable as reference oral carrier for pharmaceutical, nutraceutical, functional food and veterinary medicine where a complex formulation and performancein vivoare required.

Keywords: Alginate; Cellulose; Chitosan; Dome; Drug targeting; Oral.

MeSH terms

  • Alginates
  • Caffeine
  • Cellulose
  • Chitosan*
  • Hexuronic Acids
  • Melatonin*
  • Stomach

Substances

  • Alginates
  • Chitosan
  • Cellulose
  • Caffeine
  • Melatonin
  • Hexuronic Acids